National Medical Insurance Administration and other two departments: support medical insurance data for innovative drug research and development
2025-07-01 01:37:48
On July 1st, the National Medical Insurance Administration and other two departments issued "Several Measures to Support the High-Quality Development of Innovative Drugs", which proposed to support the use of medical insurance data for innovative drug research and development. Strengthen the information exchange and coordination among medical, medical insurance and medicine, do a good job in the management of medical insurance data resources, and promote the use of public data resources in the field of medical insurance. On the basis of ensuring data security and legal compliance, explore the provision of necessary medical insurance data services for innovative drug research and development. Relying on the national unified medical insurance information platform, do a good job in data collection and analysis of disease spectrum, clinical drug demand, etc., develop data products adapted to the R & D request of innovative drugs, and support pharmaceutical companies, scientific research institutes, medical institutions, etc. to rationally determine the R & D direction, layout R & D pipelines, and improve innovation efficiency.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
